Moxifloxacin < Back

Discover the epitome of excellence with Hemarsh Technologies exclusive selection of premium-grade Moxifloxacin Decarboxy Analog . As a renowned manufacturer and supplier, we take immense pride in providing the pharmaceutical industry with top-tier Moxifloxacin Decarboxy Analog and its high-purity impurities, tailor-made for cutting-edge research and development. Our team of experts utilizes state-of-the-art characterization techniques to meticulously ensure that our Moxifloxacin Decarboxy Analog is entirely devoid of any undesired impurities that could potentially compromise the integrity of your research. Embark on a captivating journey through our unrivaled collection of Moxifloxacin Decarboxy Analog today and witness the transformative difference firsthand!

Moxifloxacin Decarboxy Analog

Moxifloxacin Decarboxy Analog

CAS No.:

1322062-57-6 (base) ;

Molecular Formula:

C20H24FN3O2 (base) ;C20H25ClFN3O2 (HCl salt) ;

Mol. Wt.:
357.42 ;393.88 ;
Other Technical Details:

Decarboxy Moxifloxacin HCl ;1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline HCl ;

Request Quote

SALES MARKETS

  • Middle East Region (e.g.UAE)
  • Oceania
  • North America (USA Canada)
  • Africa
  • Central America (e.g. Mexico)
  • East Asia (e.g. china, Japan, Korea)
  • Europe - EU Countries
  • Europe - non EU (e.g. UK, Russia, ex-CIS countries)
  • South America (e.g. Brazil, Colombia)
  • South Asia (e.g. India, Pakistan, Sri Lanka)
  • South East Asia (e.g. Thailand, Philippines, Singapore)